Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Cash from Financing Activities (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) reported Cash from Financing Activities of -$8,000 for Q3 2026, compared with -$53,000 a year earlier.

Analysis

Aligos Therapeutics (ALGS) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Aligos Therapeutics' Cash from Financing Activities came in at $273,000, down 99.7% year-over-year; for FY2025, it came in at $101.64 million.

  • Cash from Financing Activities has a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $355,000 in FY2024 (-99.6%), $88.33 million in FY2023, $164,000 in FY2022 (-99.8%) and $78.68 million in FY2021 (-59.1%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$177,000 in Q2 2025 and a high of $101.74 million in Q1 2025.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $220,000 (Q2 2026), -$62,000 (Q1 2026) and $123,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -8.53 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 6.82 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.51 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -8,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -8,000.00
Jun 30, 2026 220,000.00
Mar 31, 2026 -62,000.00
Dec 31, 2025 123,000.00
Sep 30, 2025 -53,000.00
Jun 30, 2025 -177,000.00
Mar 31, 2025 101.74 Mn
Dec 31, 2024 97,000.00
Sep 30, 2024 -4,000.00
Jun 30, 2024 281,000.00
Mar 31, 2024 -19,000.00
Dec 31, 2023 87.94 Mn
Sep 30, 2023 -21,000.00
Jun 30, 2023 414,000.00
Mar 31, 2023 -1,000.00
Dec 31, 2022 121,000.00
Sep 30, 2022 -19,000.00
Jun 30, 2022 83,000.00
Mar 31, 2022 -21,000.00
Dec 31, 2021 552,000.00
API Access

Aligos Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALGS&period=max&api_key=YOUR_API_KEY